Lan Yao

665 total citations · 1 hit paper
39 papers, 524 citations indexed

About

Lan Yao is a scholar working on Molecular Biology, Pharmacology and Neurology. According to data from OpenAlex, Lan Yao has authored 39 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Neurology. Recurrent topics in Lan Yao's work include Traumatic Brain Injury and Neurovascular Disturbances (6 papers), Cardiac Arrest and Resuscitation (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Lan Yao is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (6 papers), Cardiac Arrest and Resuscitation (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Lan Yao collaborates with scholars based in China, United States and Spain. Lan Yao's co-authors include Pei Wang, Xianhui Liang, Yingjin Qiao, Bohan Chen, Zhangsuo Liu, Peng Wang, Zitong Huang, Guangji Wang, Lili Zhou and Fang Zhou and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Lan Yao

35 papers receiving 516 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial dysfunction in diabetic tubulopathy

2022 117 citations Lan Yao, Xianhui Liang et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lan Yao China	14	208	72	53	50	44	39	524
Chantale Simard Canada	15	216 1.0×	74 1.0×	59 1.1×	38 0.8×	40 0.9×	42	623
Serdar Erkasap Türkiye	14	137 0.7×	59 0.8×	56 1.1×	48 1.0×	38 0.9×	32	639
Zhenning Liu China	15	364 1.8×	109 1.5×	47 0.9×	112 2.2×	30 0.7×	27	674
Man Luo China	13	322 1.5×	45 0.6×	60 1.1×	39 0.8×	10 0.2×	20	541
Haitao Shen China	17	306 1.5×	84 1.2×	76 1.4×	89 1.8×	17 0.4×	32	773
Madhusudanarao Vuda Switzerland	14	290 1.4×	58 0.8×	124 2.3×	55 1.1×	22 0.5×	18	642
András Vereckei Hungary	16	115 0.6×	56 0.8×	28 0.5×	63 1.3×	22 0.5×	52	907
Ali A. Abo‐Saif Egypt	16	168 0.8×	88 1.2×	60 1.1×	30 0.6×	7 0.2×	37	593
Fabiola Giovannini Italy	10	135 0.6×	114 1.6×	95 1.8×	85 1.7×	30 0.7×	11	485

Countries citing papers authored by Lan Yao

Since Specialization

Citations

This map shows the geographic impact of Lan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Yao more than expected).

Fields of papers citing papers by Lan Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Yao. The network helps show where Lan Yao may publish in the future.

Co-authorship network of co-authors of Lan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Yao. A scholar is included among the top collaborators of Lan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Yao. Lan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Lan, et al.. (2026). The association between different ejection fractions and all-cause mortality in aged patients with hip fractures: a retrospective cohort study and the development of a predictive model. BMC Musculoskeletal Disorders.

Ye, Zhou, Xi Ye, Xin Lü, et al.. (2025). Inflammation-Targeted Molecular Imaging for Myocarditis: Recent Advances in Target Mechanisms, Probe Development, and Translational Applications. Molecular Pharmaceutics. 22(9). 5244–5256.

Eminowicz, Gemma, Jérôme Alexandre, Elena Ioana Braicu, et al.. (2025). 1221TiP GOG-3119/ENGOT-en29/TroFuse-033: A phase III, randomized study of sacituzumab tirumotecan (sac-TMT) + pembrolizumab (pembro) vs pembro alone as first-line (1L) maintenance therapy for mismatch repair-proficient (pMMR) endometrial cancer (EC). Annals of Oncology. 36. S740–S740.

Ye, Zhou, Shaojie Li, Fan Zhang, et al.. (2025). Multifunctional nanoparticles for immune regulation and oxidative stress alleviation in myocarditis. Journal of Controlled Release. 381. 113607–113607. 2 indexed citations

Dańska-Bidzińska, Anna, Vanda Salutari, Ali̇ Ayhan, et al.. (2024). 737P Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study. Annals of Oncology. 35. S561–S561. 1 indexed citations

Ye, Zhou, Xin Lü, Lei Bi, et al.. (2024). STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis. Molecular Pharmaceutics. 21(6). 2865–2877. 1 indexed citations

Zhang, Fan, et al.. (2024). Ruthenium red alleviates post-resuscitation myocardial dysfunction by upregulating mitophagy through inhibition of USP33 in a cardiac arrest rat model. European Journal of Pharmacology. 974. 176633–176633. 1 indexed citations

Pignata, Sandro, Mariusz Bidziński, M.J. Rubio Pérez, et al.. (2024). 39MO Phase III ENGOT-En9/LEAP-001 study: Lenvatinib + pembrolizumab (LEN/PEMBRO) vs chemotherapy (chemo) as first-line (1L) therapy for advanced or recurrent endometrial cancer. ESMO Open. 9. 103539–103539. 2 indexed citations

Bi, Lei, et al.. (2023). The role of (<sup>18</sup>F)-fluoro-D-glucose positron emission tomography/computed tomography in the surveillance of abnormal myocardial energy metabolism and cardiac dysfunction in a rat model of cardiopulmonary resuscitation. Diagnostic and Interventional Radiology. 29(3). 548–554. 1 indexed citations

10.

Yao, Lan, Xianhui Liang, Yingjin Qiao, et al.. (2022). Mitochondrial dysfunction in diabetic tubulopathy. Metabolism. 131. 155195–155195. 117 indexed citations breakdown →

11.

Zhang, Fan, et al.. (2021). Inhibiting Cardiac Mitochondrial Fatty Acid Oxidation Attenuates Myocardial Injury in a Rat Model of Cardiac Arrest. Oxidative Medicine and Cellular Longevity. 2021(1). 6622232–6622232. 10 indexed citations

12.

Yao, Lan, Jingwei Zhang, Bin Chen, et al.. (2020). Mechanisms and pharmacokinetic/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin. Acta Pharmacologica Sinica. 41(6). 866–878. 20 indexed citations

13.

Jin, Xiaoliang, Fang Zhou, Yan Liu, et al.. (2018). Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC–MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice. Journal of Pharmaceutical and Biomedical Analysis. 158. 1–7. 10 indexed citations

14.

Dong, Feng, Chun Ge, Jianguo Sun, et al.. (2018). Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules. Acta Pharmacologica Sinica. 39(11). 1804–1815. 12 indexed citations

15.

Zhou, Fang, Hui Ye, Qianying Chen, et al.. (2017). LC–MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1). Journal of Pharmaceutical and Biomedical Analysis. 137. 170–177. 19 indexed citations

16.

Yao, Lan, Fang Zhou, Ying Peng, et al.. (2017). Development and validation of a sensitive LC–MS/MS method without derivatization/ion-pairing agents for etimicin quantification in rat plasma, internal ear and kidney. Journal of Pharmaceutical and Biomedical Analysis. 146. 96–102. 4 indexed citations

17.

Liu, Wen‐Yue, Jingwei Zhang, Xuequan Yao, et al.. (2016). Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution. Acta Pharmacologica Sinica. 38(2). 264–276. 35 indexed citations

18.

Zhou, Lili, et al.. (2016). Therapeutic effects of various methods of MSC transplantation on cerebral resuscitation following cardiac arrest in rats. Molecular Medicine Reports. 13(4). 3043–3051. 15 indexed citations

19.

Li, Hui, et al.. (2015). Effect of ethyl acetate extract from coreopsis tinctoria on diabetic SD rats induced by STZ. Zhongguo yaolixue tongbao. 2 indexed citations

20.

Oakley, Deborah, et al.. (1999). Combining Qualitative with Quantitative Approaches to Study Contraceptive Pill Use. Journal of women's health. 8(2). 249–257. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact